Notes: Cytokine release syndrome (CRS) occurs after treatment of some types of immunotherapy, such as monoclonal antibodies and CAR-T cells, when a large number of cytokines are rapidly released into the blood stream from immune cells affected by the immunotherapy. Symptoms include fever, headache, and a rapid heartbeat, but severe reactions can be fatal. The Q-Plex™ Human Cytokine Release Syndrome (16-Plex) is a fully quantitative ELISA-based chemiluminescent assay allowing the concurrent measurement of 16 biomarkers or analytes. Using only 25 µl of sample per well, up to 80 samples can be assayed for all 16 markers in the panel within 4.83 hours. The Q-Plex™ Human Cytokine Release Syndrome (16-Plex) provides researchers an easy to use and cost-effective means of generating a cytokine profile for each sample. Q-Plex plates are built by adsorbing 16 distinct capture antibodies in a defined array to the bottom of each well. Our high-quality reagents help ensure the accuracy of your results. Q-Plex™ chemiluminescent assays require analysis via the Q-View™ imaging system. See Item No. 28264 to view pricing and specifications for the Q-View™ Imager LS. Species: Human Assay Type: Sandwich Sample Type: Human Serum, EDTA/Heparin Plasma Assay Length: 4.83 hours Specificity: All analytes Volume Required Per Well: 25 µl, minimum Detection Method: Q-View™ Chemiluminescent Imaging System Item No. 28264 Multiplex Format: 96-well solid plate [Quansys Catalog No. 119733HU]
English
Deutsch
